R
Relmada Therapeutics, Inc. (RLMD)
NCM – Real vaqt narxi. Valyuta: USD
7.45
+0.09 (1.22%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
7.45
+0.09 (1.22%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $11.56 based on the ratings of 9 analysts. The high is $26.00 and the low is $1.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 1 | $ 11.56 | $ 26 |
| O’zgarish | -86.34% | 57.92% | 255.19% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-24 | 63.93% | Piper Sandler | $12 | Initiates Coverage On | Overweight |
| 2026-03-20 | 159.56% | Mizuho | $10 → $19 | Maintains | Outperform |
| 2026-03-02 | 91.26% | LUCID CAPITAL MARKETS | $14 | Initiates Coverage On | Buy |
| 2026-01-23 | 9.29% | Leerink Partners | $8 | Upgrades | Market Perform → Outperform |
| 2025-12-22 | 22.95% | Jefferies | $9 | Initiates Coverage On | Buy |